Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

Donald P Tashkin1, Dennis E Doherty2, Edward Kerwin3, Carlos E Matiz-Bueno4, Barbara Knorr5, Tulin Shekar5, Sibabrata Banerjee5, Heribert Staudinger51David Geffen School of Medicine at UCLA, Los Angeles, CA, 2Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky, Lexington...

Full description

Bibliographic Details
Main Authors: Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno C, Knorr B, Shekar T, Banerjee S, Staudinger H
Format: Article
Language:English
Published: Dove Medical Press 2012-02-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/efficacy-and-safety-of-a-fixed-dose-combination-of-mometasone-furoate--a9201

Internet

http://www.dovepress.com/efficacy-and-safety-of-a-fixed-dose-combination-of-mometasone-furoate--a9201

Similar Items